Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 126 Lung Neoplasms 51 Triple Negative Breast Neoplasms 35 Breast Neoplasms 34 Small Cell Lung Carcinoma 30 Ovarian Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 25 Neoplasm Metastasis 21 Fallopian Tube Neoplasms 20 Endometrial Neoplasms 19 Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Head and Neck Neoplasms 13 Colorectal Neoplasms 11 Carcinoma 11 Prostatic Neoplasms 9 Oropharyngeal Neoplasms 9 Esophageal Neoplasms 9 Urinary Bladder Neoplasms 8 Carcinoma, Transitional Cell 8 Pancreatic Neoplasms 7 Carcinoma, Squamous Cell 7 Lung Diseases 6 Laryngeal Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Adenocarcinoma of Lung 6 Uterine Cervical Neoplasms 5 Respiratory Tract Neoplasms 5 Mouth Neoplasms 5 Mesothelioma 5

Interventions

Gemcitabine 3 Cisplatin 3 toripalimab 2 Radiotherapy, Intensity-Modulated 2 spartalizumab 1 atezolizumab 1 Surveys and Questionnaires 1 Phantoms, Imaging 1 Observation 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Neoplasms × Carboplatin × 90 days × Clear all

NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡